EN DE

Hangzhou Toka Ink Co (688571) Fair Value & Analysis

Basic Materials · CN · Market cap 3.4B CNY

HT Hangzhou Toka Ink Co 688571 · SHG
Price¥9.43
Fair Value¥3.68
Upside-61.0%
Quality49/100
Watch Hangzhou Toka Ink Co for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 8.6% net margin
negative free cash flow
1.74% dividend yield
Mixed vs. peers (6/12)
Narrow moat 42/100
Evidence: High Range ¥3.26 – ¥4.66 Share as image

Fair value as of: Jul 12, 2026

From 15 valuation models · updated 29 days ago

Share price −0.6% over the past month.

Below-average quality, and screening another 61% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥4.66). The favourable scenario is already priced in.
  • Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥11.06 ¥4.17 Fair Value ¥3.68 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 12, 2026.

How to read this chart

60‑month range ¥4.17 – ¥11.06 · fair‑value band ¥3.26 – ¥4.66 · the ¥9.43 price screens above the ¥3.68 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 12, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Hangzhou Toka Ink Co (688571) currently trades at ¥9.43, while our model-based Fair Value estimate is ¥3.68, implying the stock looks roughly 61.0% overvalued today. The Quality Score stands at 49/100 (below-average quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Hangzhou Toka Ink Co generated revenue of 1.3B CNY at a net margin of 8.6%. Revenue grew 5.5% year over year. It earns a return on equity of 5.7%. The balance sheet holds a net cash position of 825M CNY. Fundamentals as of Jul 12, 2026

Our scenario range runs from ¥3.26 (bear case) to ¥4.66 (bull case); at ¥9.43, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 38% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -61%, 688571 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ¥3.14 ¥3.28 ¥3.37 76
Gordon GGM ¥1.73 ¥2.57 ¥3.43 70
Growth-Adj P/E ¥2.43 ¥3.47 ¥4.51 68
All 15 models by family
Earnings-Based
Graham-Dodd ¥1.74 ¥3.68 ¥4.66 54
PEG = 1.0 ¥0.5600 ¥0.7900 ¥1.03 46
EPV ¥3.94 ¥4.30 ¥4.61 59
Dividend Discount
Gordon GGM ¥1.73 ¥2.57 ¥3.43 70
DDM Multi-Stage ¥1.73 ¥2.44 ¥3.21 61
Multiples
P/E Multiple ¥3.26 ¥4.35 ¥5.44 63
P/S Multiple ¥3.26 ¥4.35 ¥5.44 58
P/B Multiple ¥3.26 ¥4.35 ¥5.44 55
EV/EBIT ¥4.58 ¥5.56 ¥6.53 53
EV/EBITDA ¥4.59 ¥5.56 ¥6.54 54
EV/Revenue ¥4.19 ¥5.28 ¥6.36 43
Asset-Based
NCAV (Graham) ¥1.98 ¥2.65 ¥3.95 50
Economic Profit
Residual Income ¥3.14 ¥3.28 ¥3.37 76
ROIC Compounder ¥3.94 ¥4.39 ¥4.87 67
Growth Earnings
Growth-Adj P/E ¥2.43 ¥3.47 ¥4.51 68

Widest divergence: Multiples (¥4.35) versus Dividend Discount (¥2.44). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) 1.3B CNY
Revenue growth (YoY) +5.5%
Net margin 8.6%
Return on equity 5.7%
Free cash flow −17.5M CNY FY2025
P/E ratio 30.5
More key figures
Operating margin 10.8%
EPS (TTM) ¥0.2600
Dividend yield 1.7%
Net cash 825M CNY FY2024

Figures from reported company fundamentals · as of Jul 12, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 49/100

Of which business quality 51 · Market factors (momentum, volatility) 65

Profitability 32
Margins and returns on capital today
Quality Growth 14
Are margins and returns improving?
Cashflow 32
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 52
Disciplined investing over empire-building
Low Volatility 53
Calm price path (market factor)
Momentum 69
Price trend over the last 3–12 months (market factor)
52W Momentum 71
Distance to the 52-week high (market factor)
Net Issuance 70
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Hangzhou Toka Ink Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ink products, digital materials, and functional materials in China and internationally.

Full company description

Hangzhou Toka Ink Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of ink products, digital materials, and functional materials in China and internationally. The company offers UV printing inks for various materials, such as paper, paper-plastic composite films, metal cardboards, and plastic sheets; offset printing inks for the printing of packaging and publications, including textbooks, teaching aids, and children's books, etc.; liquid inks for plastic and composite films, paper and paper-plastic materials, and other materials; and high-biomass and special inks. It also provides digital inkjet printing inks for digital printing materials comprising paper, plastic, film, and fiber, etc., as well as light box advertisements; functional materials, including varnish and matte oil; primers; new energy, electronics, decoration building materials, and other industrial manufacturing fields; application of laser holographic image anti-counterfeiting technology; and floor beautification and painting of hospitals, food workshops, logistics warehouses, offices, and entertainment venues. Hangzhou Toka Ink Co.,Ltd. was incorporated in 1988 and is headquartered in Hangzhou, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Hangzhou Toka Ink Co reported revenue of ¥1.2B in FY2025 versus ¥1.1B in FY2021, a compound +2.1%/yr. Reported net income was ¥109M in FY2025, compounding −1.0%/yr from FY2021.

Growth Quality 22/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
1.2B CNY
Latest YoY
−1.6%
Avg. growth/yr (3Y)
+3.1%
Avg. growth/yr (5Y)
+4.8%
Avg. growth/yr (12Y)
+2.1%
Revenue +2.1%/yr
FY21 ¥1.1B
FY22 ¥1.1B
FY23 ¥1.2B
FY24 ¥1.3B
FY25 ¥1.2B
Net income −1.0%/yr
FY21 ¥113M
FY22 ¥79.6M
FY23 ¥123M
FY24 ¥139M
FY25 ¥109M

688571 screens 61% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Hangzhou Toka Ink Co Fair Value". https://www.fairvalue-calculator.com/stock/688571

Peer Group

Specialty Chemicals · 676 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 49 · Below median
Fair Value upside −61% · Bottom 25%
Return on equity (TTM) 6% · Above median
Return on assets 3% · Above median
Net margin (TTM) 9% · Above median
Operating margin (TTM) 11% · Above median
Revenue growth 6% · Above median
Dividend yield (TTM) 1.7% · Above median

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 30.5× · Pricier than median
P/B 2.00× · Pricier than median
P/S (TTM) 2.66× · Pricier than median
EV/EBITDA 16.8× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 28 · sector 19
PAST 23 · sector 23
HEALTH 0 · sector 95
DIVIDEND 35 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Hangzhou Toka Ink Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Hangzhou Toka Ink Co (688571) overvalued or undervalued?
As of Jul 12, 2026, our model estimates a fair value of ¥3.68 versus a price of ¥9.43, about −61% (overvalued).
What is the fair value of 688571?
Our model-based fair value for Hangzhou Toka Ink Co is ¥3.68 (as of Jul 12, 2026), built from audited fundamentals. The current price is ¥9.43.
What is the quality score of 688571?
Hangzhou Toka Ink Co has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Hangzhou Toka Ink Co (688571)?
Hangzhou Toka Ink Co reported trailing-twelve-month revenue of about 1.3B CNY (latest available figure, as of Jul 12, 2026).
What is the net profit margin of 688571?
The net profit margin of Hangzhou Toka Ink Co is about 8.6%, meaning it keeps roughly 8.6% of revenue as net income. Based on the latest reported figures.
Does Hangzhou Toka Ink Co pay a dividend?
Hangzhou Toka Ink Co currently shows a dividend yield of about 1.74% relative to its recent price (as of Jul 12, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Hangzhou Toka Ink Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.